Article

Insights into Intestinal P-glycoprotein Function using Talinolol: A PBPK Modeling Approach

2023-11-22

Abstract excerpt

<h4>ABSTRACT</h4> Talinolol is a cardioselective beta-blocker that was previously used to treat heart failure and myocardial infarction. Following the development of new, more effective beta-blockers with better study results, talinolol is now only used clinically for the treatment of arterial hypertension. In basic science, talinolol continues to be used as a test substance due to its pharmacokinetics. Its intes...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8adbfa47-ce9e-55e8-9c49-1ce428b250f7
DOI: 10.1101/2023.11.21.568168

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Insights into Intestinal P-glycoprotein Function using Talinolol: A PBPK Modeling ApproachDOI 10.1101/2023.11.21.568168Read

Importance of P‐glycoprotein for drug disposition in humansSemantic proximity Read

Transporters and drug-drug interactions: important determinants of drug disposition and effects.Semantic proximity Read

Evaluation of in vivo P-glycoprotein phenotyping probes: a need for validation.Semantic proximity Read

Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters.Semantic proximity Read

Expression, regulation and function of intestinal drug transporters: an updateSemantic proximity Read

Recent progress in in vivo phenotyping technologies for better prediction of transporter-mediated drug-drug interactions.Semantic proximity Read

Disease‐Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter ConsortiumSemantic proximity Read

The role of the efflux transporter, P‐glycoprotein, at the blood–brain barrier in drug discoverySemantic proximity Read

A Digital Twin of Glimepiride for Personalized and Stratified Diabetes TreatmentSemantic proximity Read

No sex difference in overall P-glycoprotein activity as assessed by talinolol disposition in humans.Semantic proximity Read

Unexpected lack of effect of the rifampin-induced P-glycoprotein on the oral bioavailability of its substrate, talinolol, in humans: implication in phenotyping.Semantic proximity Read

Transporters and drug therapy: implications for drug disposition and disease.Semantic proximity Read